Find A Physician
More on New York Weill Cornell Researchers Report CT Screening of Patients at Risk for Lung Cancer Saves Lives
Hospital News
More on New York Weill Cornell Researchers Report CT Screening of Patients at Risk for Lung Cancer Saves Lives
- Annual CT Screening for Lung Cancer Is Cost-Effective for High-Risk Persons, Study Finds
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Female Smokers Face Double the Risk for Lung Cancer Compared to Male Smokers, NewYork-Presbyterian/Weill Cornell Study Finds
- Female Smokers Twice as Likely as Men To Develop Lung Cancer, Weill Cornell Study Finds
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Landmark Study Reveals Lung Cancer 10-Year Survival Dramatically Improves With Annual CT Screening and Prompt Treatment
- Lung Cancer CT Screening Is Cost-Effective, Weill Cornell Study Shows
- Lung Cancer Screening Regimen Provides Opportunity for Cure
- New Book by NewYork Weill Cornell Radiologist Offers Hope to Those Who May Face Lung Cancer
- New Research To Address Pressing Question: Will Early Lung Cancer Detection Lead to Tobacco Cessation?
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- New York Weill Cornell To Lead Statewide Consortium in Early CT Screening for Lung Cancer
- Smokers and Former Smokers Should Be Screened for Lung Cancer, Even if They Do not Have Symptoms
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
Research and Clinical Trials
More on New York Weill Cornell Researchers Report CT Screening of Patients at Risk for Lung Cancer Saves Lives
Health Library
More on New York Weill Cornell Researchers Report CT Screening of Patients at Risk for Lung Cancer Saves Lives
Clinical Services
More on New York Weill Cornell Researchers Report CT Screening of Patients at Risk for Lung Cancer Saves Lives
New York Weill Cornell Researchers Report CT Screening of Patients at Risk for Lung Cancer Saves Lives
NEW YORK (Jul 8, 1999)
A painless, 20-second test could save more than 100,000 lives annually in the United States by detecting lung cancer at an early, curable stage, say researchers at Weill Medical of Cornell University and New York Presbyterian Hospital (New York Weill Cornell Center). Their dramatic findings, published in the July 10th issue of The Lancet, show that low-dose CT (low radiation dose computed tomography) can find lung tumors long before they appear on traditional chest x-rays.
Lung cancer is the leading cause of cancer mortality in the United States. More women and men die of lung cancer than from breast, prostate, and colorectal cancer combined. This year, more than 160,000 Americans will die from this terrible disease, which is usually diagnosed only after it has advanced too far to be stopped.
"Lung cancer is deadly because we never had a good way to find it early. Now we do," said Claudia I. Henschke, M.D., Ph.D., Principal Investigator of the study, and Professor of Radiology and Division Chief of Chest Imaging at the New York Weill Cornell Center of New York Presbyterian Hospital. "CT screening transforms the prognosis for lung cancer, just as mammography did for breast cancer and the PAP test did for cervical cancer."
The results come from the Early Lung Cancer Action Program (ELCAP), the first major study of baseline screening by low-dose CT in 1,000 smokers and former smokers age 60 and older. The CT test detected 23 early-stage lung cancers. Only 4 of the tumors were visible on chest x-ray, the standard diagnostic imaging technique. None of the patients had any symptoms of lung cancer.
Lung cancer tumors typically are about the size of an orange by the time they’re discovered. In contrast, most of the lesions detected on CT were no bigger than a grain of rice. "The current five-year survival rate for lung cancer is only 14 percent. But that could soar to 80 percent if all smokers and ex-smokers received annual CT exams and early treatment," commented Dr. Henschke.
The low-dose CT used for screening requires less than 20 seconds of scanning time and entails only slightly more radiation than a chest x-ray. Moreover, this diagnostic test is affordable, at a cost relative to the average chest x-ray. Follow-up tests track suspicious nodules to avoid unnecessary biopsies.
Along with Dr. Henschke, the New York Weill Cornell research team includes David F. Yankelevitz, M.D.; Olli S. Miettinen, M.D., Ph.D.; Daniel M. Libby, M.D.; Mark W. Pasmantier, M.D.; June H. Koizumi, M.D.; Nasser K. Altorki, M.D.; and James P. Smith, M.D. This study was done in collaboration with New York University (NYU) Medical Center researchers.
